FIELD: chemistry.
SUBSTANCE: invention relates to novel statin derivatives of formula: 
or its pharmaceutically acceptable salt or stereoisomer, where: X represents -O-, R represents statin residue of formula:
, Y represents a) straight or branched C1-C20alkylene, mainly C1-C10, optionally substituted with one or more OH;
b)
,
where n equals from 0 to 20, and n1 from 1 to 20; on condition that when Y represents b), group -ONO2 is bonded with -(CH2)n 1;
g)
,
where X2 represents -O, n3 from 1 to 6, mainly from 1 to 4, R2 represents H or CH3.
EFFECT: obtaining compounds which possess anti-inflammatory, antithrombotic and antithrombocytic activity, which allows to use them for production of medication for reduction of cholesterol and triglycerides levels and/or for increasing HDL-C level.
14 cl, 6 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF NITROOXYDERIVATIVE DRUG FOR TREATING MUSCULAR DYSTROPHY | 2007 |
|
RU2429828C2 |
| NITROGEN OXIDE-RELEASING COMPOUNDS | 2007 |
|
RU2560144C2 |
| AMORPHOUS HMG-KoA REDUCTASE INHIBITORS AND A METHOD FOR PREPARATION THEREOF | 2002 |
|
RU2309141C2 |
| NITROOXY-DERIVATIVES OF LOSARTAN, VALSARTAN, CANDESARTAN, TELMISARTAN EPROSARTAN AND OLMESARTAN AS BLOCKERS OF ANGIOTENSIN II RECEPTORS FOR TREATING CARDIOVASCULAR DISEASES | 2004 |
|
RU2374240C2 |
| PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF LIPID METABOLISM DISORDER | 2001 |
|
RU2246302C2 |
| PHARMACEUTICAL COMPOSITION OF STATINS WITH PREBIOTIC FOR THERAPY OF HYPERCHOLESTEREMIA AND HYPERLIPIDEMIA | 2014 |
|
RU2591079C2 |
| CRYSTALLINE FORMS VI AND VII OF ATORVASTATIN CALCIUM SALT | 2002 |
|
RU2304139C2 |
| SYNTHESIS OF ATORVASTATINE AND INTERMEDIATE PHENYLBORONATE (VARIANTS) | 2001 |
|
RU2269515C2 |
| NITROOXYDERIVATIVE STEROIDS | 2006 |
|
RU2415864C2 |
| METHOD OF PRODUCTION OF MEVALONIC ACID DERIVATIVES INHIBITING HMG-COA REDUCTASE | 2003 |
|
RU2335500C2 |
